From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities.
http://biopharmadealmakers.nature.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
1.1 seconds
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
10
SITE IP
23.21.252.10
LOAD TIME
1.11 sec
SCORE
6.2
BioPharma Dealmakers | biopharmadealmakers.nature.com Reviews
https://biopharmadealmakers.nature.com
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities.
biopharmadealmakers.nature.com
Raveena Bhambra | BioPharma Dealmakers
https://biopharmadealmakers.nature.com/users/5058-raveena-bhambra
A Nature Research Service. Visit https:/ biopharmadealmakers.nature.com/. We use cookies on our website to ensure you have a good experience. Read our cookie policy. For more information or continue browsing. By continuing to browse our website you are consenting to our cookie policy. Editor, BioPharma Dealmakers , Nature Publishing Group. More About Raveena Bhambra. Therapeutic areas of interest. Our March 2017 issue is live. Our March 2017 issue is live. Mar 01, 2017. Where do our clients come from?
Deal Trends | BioPharma Dealmakers
https://biopharmadealmakers.nature.com/channels/253-deal-trends
A Nature Research Service. Visit https:/ biopharmadealmakers.nature.com/. We use cookies on our website to ensure you have a good experience. Read our cookie policy. For more information or continue browsing. By continuing to browse our website you are consenting to our cookie policy. On trends in dealmaking. Microbiome partnerships: an expanding network. Microbiome partnerships: an expanding network. Mar 07, 2017. Feb 15, 2017. Bispecific antibody platforms spawn dealmaking boom. Oct 28, 2016.
OncoSec | BioPharma Dealmakers
https://biopharmadealmakers.nature.com/users/12641-oncosec
A Nature Research Service. Visit https:/ biopharmadealmakers.nature.com/. We use cookies on our website to ensure you have a good experience. Read our cookie policy. For more information or continue browsing. By continuing to browse our website you are consenting to our cookie policy. Arming the Immune System to Fight Cancer. OncoSec’s platform, ImmunoPulse, delivers immune modulators directly into tumors to activate an orchestrated anti-tumor immune response. Feb 29, 2016. Website Terms of Use.
GSK | BioPharma Dealmakers
https://biopharmadealmakers.nature.com/users/16103-gsk
A Nature Research Service. Visit https:/ biopharmadealmakers.nature.com/. We use cookies on our website to ensure you have a good experience. Read our cookie policy. For more information or continue browsing. By continuing to browse our website you are consenting to our cookie policy. One of the worlds leading vaccine companies. Accelerating vaccine R&D through collaboration. May 23, 2016. Website Terms of Use. Latest Edition (November 2016).
Latest Edition (November 2016) | BioPharma Dealmakers
https://biopharmadealmakers.nature.com/channels/259-latest-edition-november-2016
A Nature Research Service. Visit https:/ biopharmadealmakers.nature.com/. We use cookies on our website to ensure you have a good experience. Read our cookie policy. For more information or continue browsing. By continuing to browse our website you are consenting to our cookie policy. Latest Edition (November 2016). All the features from the latest edition of. Latest Edition (November 2016). Novel powerhouse to energize drug performance. Feb 23, 2017. Trends in pharmaceutical mergers and acquisitions.
TOTAL PAGES IN THIS WEBSITE
20
Journal home : Nature Biotechnology
http://www.nature.com/nbt/index.html
Jump to main content. News 9 August 2016. Biogen and UPenn join forces to commercialize gene therapies. The recent gene therapy alliance between Biogen and the University of Pennsylvania offers further confirmation that the industrialization of gene therapy, though by no means complete, is now under way in earnest. Editorial 9 August 2016. What Brexit means for biotech. Patents 9 August 2016. The rise and fall of innovation in biofuels. Stevan C Albers et al. Blog 4 August 2016. Corey E Bakalarski et al.
Supporters - SachsForum
http://www.sachsforum.com/supporters.html
4th Annual MedTech and Digital Health Forum. 16th Annual Biotech in Europe Investor Forum. 10th Annual European Life Sciences CEO Forum and Exhibition. 2nd Annual Neuroscience BioPartnering and Investment Forum. 5th Annual Cancer BioPartnering and Investment Forum. 2nd Immuno-Oncology BD&L and Investment Forum. 9th Annual European Life Science CEO Forum and Exhibition, 15th-16th March 2016, Hilton Zurich Airport Hotel. 15th Annual Biotech in Europe Forum. 3rd Annual MedTech and Digital Health Forum.
Of Schemes and Memes Blog: a community blog from nature.com
http://blogs.nature.com/ofschemesandmemes
Of Schemes and Memes Blog. A community blog from nature.com. Journal metrics: handle with care. Posted by Lillienne Zen. We have recently updated the journal metrics page for Nature Research to include an array of additional bibliometric data ( www.nature.com/npg /company info/journal metrics.html. The Nature-branded research and reviews journals, and. And the Nature-branded research journals, articles published in 2013 and 2014 and categorized as Article or Review in Web of Science were selected. Articl...
Journal home : Nature Biotechnology
http://www.nature.com/nbt
Jump to main content. News 9 August 2016. Synthetic human genome set to spur applications. Of several biotech applications that could arise from Human Genome Project-Write, a proposed project to fully synthesize the human genome, perhaps the most compelling is the creation of ultrasafe mammalian cell lines for recombinant protein production. Editorial 9 August 2016. What Brexit means for biotech. Patents 9 August 2016. The rise and fall of innovation in biofuels. Stevan C Albers et al. Blog 12 August 2016.
TOTAL LINKS TO THIS WEBSITE
10
BIOPHARMACY
Martes, 14 de agosto de 2012. Microchip 'could improve detection of substandard drugs'. A new way of detecting substandard drugs will be put to field tests soon. A microchip tailored to detect a specific active ingredient in a drug that costs only a few US cents to produce could help in efforts to detect counterfeit and substandard medicines in the developing world, researchers say. Zaman said the new approach is better than a one-size-fits-all strategy, because the probes for each type of drug are more ...
biopharmacy.info
The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).
biopharmacy.net at Directnic
Home
BioPharma Data Services(BDS) was formed in 2005. Our Principal. Has several years of Pharmaceutical experience. BDS consultants. Have experience in all phases of clinical trials and are skilled in. Preparing electronic documents for filing a New Drug Application. BDS provides Data Analytical services for the BioPharmaceutical. Industry. We specialize in developing Tables, Listings and Graphs. For all phases of Clinical Trials. We also provide statistical analysis.
Home | Bio Pharma Day Milano 2018
Vai al contenuto principale. Milano, 21 marzo 2018. Milano, 21 marzo 2018. WHAT IS BIO PHARMA DAY? Bio Pharma Day is the exclusive career day organized by Jobadvisor, entirely dedicated to companies, research institutions, recruitment agencies and educational institutions in the. Medical, biomedical, healthcare, pharmaceutical and biotechnological sectors. Bio Pharma Day is addressed to. Students, graduates and young professionals. Medical and biomedical engineering background. From 09.30 to 16.30. Asses...
biopharmadealmakers.nature.com
BioPharma Dealmakers
A Nature Research Service. Visit https:/ biopharmadealmakers.nature.com/. We use cookies on our website to ensure you have a good experience. Read our cookie policy. For more information or continue browsing. By continuing to browse our website you are consenting to our cookie policy. The destination for life sciences companies and partnering professionals looking to make connections and get the latest on their industry, from the publishers of Nature. Partnerships key to combating viral epidemics. Publis...
BioPharma Deals
A blog to discuss biotechnology and pharmaceutical financing deals, including venture capital funding, mergers and acquisitions, and licensing deals. Posted on Thursday, December 24, 2009 - 2 comments. Http:/ biopharmadeals.wordpress.com/. Links to this post. Is The Risk Worth The Reward? Posted on Saturday, November 18, 2006 - 1 comments. Merck acquisition of Sirna. One thing to keep in mind is that the higher premiums are only part of the picture. It is often overlooked that pharmaceutical companie...
biopharmadeals - Home
Alliance Advisory and Management Counsel. This site is currently under renovation. Please check back in a few days. Thank you for your interest. In the mean time, we'd love to hear from you.
BioPharma Deals | Random thoughts about the biopharmaceutical industry
Random thoughts about the biopharmaceutical industry. An Example of Financing Risk in a Microcap Biotech Stock. I previously blogged about financing risks. Associated with microcap biotech companies. In this post, I wanted examine a real-life example of a microcap biotech that recently had to raise capital. On February 12th, ImmunoCellular Therapeutics (IMUC) raised approximately $14.6 million. If you look at IMUC’s 10-Q. In 2015. Management had stated that the Phase 3 trial could enroll 600 patients.
Biopharmadesign
Biopharmadesign is maintained by Dr Thorir Bjornsson, whose career has spanned both academia and industry. Dr Bjornsson's interest areas involve ways to improve innovation and productivity in the biopharmaceutical sector, including improved knowledge management, novel business processes and organizational designs. Note the opinions expressed on these pages are solely those of Dr Bjornsson. Hundreds of New Anti-cancer Drugs! Below is a list of proposed next steps and activities. Some of these have bee...
BioPharmaDev, Inc.
BioPharmaDev, Inc. br Phone: 949.838.7161 br Email: a href=mailto:contact@biopharmadev.com contact@biopharmadev.com /a br / a href=http:/ biopharmadev.com/chinese class=tagline link 中文 /a. Phone: 949.838.7161. Always ensuring highest quality and incomparable service. Learn More About Services for Pharmaceutical and Biotech. Always ensuring highest quality and incomparable service. Learn More About Services for Medical Devices. Always ensuring highest quality and incomparable service.
SOCIAL ENGAGEMENT